EMA Authorised: Luveris (lutropin alfa) — Merck Europe B.V.

View source ↗

Summary

The EMA authorised Luveris (lutropin alfa) by Merck Europe B.V. for ovulation induction in female infertility.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Luveris (lutropin alfa)

Snippet

Status: Authorised. Therapeutic area: Ovulation Induction;Infertility, Female. MAH: Merck Europe B.V.. Decision date: 19/07/2024